A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia.

BACKGROUND:Pentavalent antimonials (Sb5) are the first-line drugs for treating cutaneous leishmaniasis in Colombia; however, given problems with toxicity, compliance, availability, and cost, it is imperative to look for better therapeutic options. Intravenous amphotericin B (AmB) has been used exten...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Liliana López, Iván Vélez, Claudia Asela, Claudia Cruz, Fabiana Alves, Sara Robledo, Byron Arana
Formato: Artigo
Lenguaje:Inglês
Publicado: Public Library of Science (PLoS) 2018-07-01
Colección:PLoS Neglected Tropical Diseases
Acceso en línea:http://europepmc.org/articles/PMC6078324?pdf=render
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares